• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[上尿路癌患者的副肿瘤综合征]

[A paraneoplastic syndrome in patients with a carcinoma of the upper urinary tract].

作者信息

Stratev S

出版信息

Khirurgiia (Sofiia). 1997;50(4):10-1.

PMID:9739850
Abstract

Evidence of a paraneoplastic syndrome is established in 21/63 patients (33.3 per cent) presenting upper urinary tract tumors. It becomes manifest 2-5 months before diagnosing the basic malignant disease. Subfebrility and anemia are the commonest paraneoplastic symptoms, clinically expressed in 15.87 per cent of cases. As the result of radical treatment, this symptomatology disappears within 10 days to two months after resorting to radical surgery. The paraneoplastic syndrome may be interpreted as a clinical "tumor marker;, indicating whether or not the treatment is radical, or the occurrence of a relapse and metastases may be anticipated.

摘要

在63例上尿路肿瘤患者中,21例(33.3%)确诊为副肿瘤综合征。该综合征在诊断出原发性恶性疾病前2至5个月出现。低热和贫血是最常见的副肿瘤症状,临床上15.87%的病例有此表现。经过根治性治疗后,这种症状在采取根治性手术后10天至两个月内消失。副肿瘤综合征可被视为一种临床“肿瘤标志物”,用于指示治疗是否彻底,或是否可能出现复发和转移。

相似文献

1
[A paraneoplastic syndrome in patients with a carcinoma of the upper urinary tract].[上尿路癌患者的副肿瘤综合征]
Khirurgiia (Sofiia). 1997;50(4):10-1.
2
Sarcomatoid carcinoma of the upper urinary tract: clinical outcome and molecular characterization.上尿路肉瘤样癌:临床结局与分子特征
Hum Pathol. 2009 Feb;40(2):211-7. doi: 10.1016/j.humpath.2008.07.003. Epub 2008 Sep 16.
3
Imaging of urothelial cancers: what the urologist needs to know.尿路上皮癌的影像学表现:泌尿科医生须知。
AJR Am J Roentgenol. 2011 Jun;196(6):1249-54. doi: 10.2214/AJR.10.6232.
4
Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.p63和p53表达在上尿路移行细胞癌中的预后影响
Urology. 2004 Jun;63(6):1079-83. doi: 10.1016/j.urology.2004.01.009.
5
Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature.上尿路尿路上皮癌的预后因素:对当前文献的综合回顾。
Eur Urol. 2012 Jul;62(1):100-14. doi: 10.1016/j.eururo.2012.02.030. Epub 2012 Feb 23.
6
Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma.荧光原位杂交在上尿路尿路上皮癌诊断中的应用
Cancer Genet Cytogenet. 2009 Mar;189(2):93-7. doi: 10.1016/j.cancergencyto.2008.10.015.
7
Prospective evaluation of molecular markers for the staging and prognosis of upper tract urothelial carcinoma.上尿路尿路上皮癌分期及预后分子标志物的前瞻性评估
Eur Urol. 2012 Jul;62(1):e27-9. doi: 10.1016/j.eururo.2012.04.031. Epub 2012 Apr 17.
8
Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.膀胱移行细胞癌根治性膀胱切除术后上尿路尿路上皮复发:1069例患者10年随访分析
J Urol. 2007 Jun;177(6):2088-94. doi: 10.1016/j.juro.2007.01.133.
9
The modern management of upper urinary tract urothelial cancer: tumour diagnosis, grading and staging.上尿路尿路上皮癌的现代管理:肿瘤诊断、分级和分期
BJU Int. 2007 May;99(5):973-7. doi: 10.1111/j.1464-410X.2007.06801.x.
10
Prognostic factors for upper urinary tract urothelial carcinoma after nephroureterectomy.肾输尿管切除术后上尿路尿路上皮癌的预后因素
Urol Int. 2012;88(2):225-31. doi: 10.1159/000335274. Epub 2012 Jan 11.